- Home
- CLRB vs BREA Comparison
CLRB vs BREA Comparison
Compare CLRB & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- BREA
- Stock Information
- Founded
- CLRB 2002
- BREA 2022
- Country
- CLRB United States
- BREA Ireland
- Employees
- CLRB N/A
- BREA N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- CLRB Health Care
- BREA Consumer Discretionary
- Exchange
- CLRB Nasdaq
- BREA Nasdaq
- Market Cap
- CLRB 14.2M
- BREA 14.8M
- IPO Year
- CLRB N/A
- BREA 2023
- Fundamental
- Price
- CLRB $5.49
- BREA $24.90
- Analyst Decision
- CLRB Hold
- BREA
- Analyst Count
- CLRB 2
- BREA 0
- Target Price
- CLRB N/A
- BREA N/A
- AVG Volume (30 Days)
- CLRB 89.6K
- BREA 1.0M
- Earning Date
- CLRB 11-17-2025
- BREA 01-01-0001
- Dividend Yield
- CLRB N/A
- BREA N/A
- EPS Growth
- CLRB N/A
- BREA N/A
- EPS
- CLRB N/A
- BREA N/A
- Revenue
- CLRB N/A
- BREA $2,988,009.00
- Revenue This Year
- CLRB N/A
- BREA N/A
- Revenue Next Year
- CLRB N/A
- BREA N/A
- P/E Ratio
- CLRB N/A
- BREA N/A
- Revenue Growth
- CLRB N/A
- BREA 151.51
- 52 Week Low
- CLRB $4.11
- BREA $5.00
- 52 Week High
- CLRB $67.50
- BREA $52.95
- Technical
- Relative Strength Index (RSI)
- CLRB 60.03
- BREA 93.44
- Support Level
- CLRB $5.05
- BREA $6.92
- Resistance Level
- CLRB $5.34
- BREA $14.84
- Average True Range (ATR)
- CLRB 0.34
- BREA 4.16
- MACD
- CLRB 0.07
- BREA 1.30
- Stochastic Oscillator
- CLRB 98.15
- BREA 40.62
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.